Le Lézard
Classified in: Health
Subject: PDT

ClearHealth Quality Institute Unveils New Telemedicine Accreditation Program


ANNAPOLIS, Md., March 20, 2018 /PRNewswire/ -- ClearHealth Quality Institutetm (CHQI), an independent health care accrediting body, announced today the launch of CHQI's new Telemedicine Accreditation Program (TAP).

The program is now accepting applicants and the TAP Standards and Guide are now available at www.CHQI.com.

As the only telemedicine or telehealth accreditation program endorsed by the American Telemedicine Association (ATA), the TAP accreditation seal provides consumers with an easy-to-identify confirmation of quality from an independent third-party organization. This patient and consumer benefit had previously been unavailable for telehealth services, which are a rapidly expanding segment of the health care market.

"The CHQI Telemedicine Standards Committee, comprised of relevant stakeholders such as providers, regulators, payers, consumers and technology companies, thoroughly vetted the TAP standards to ensure they are the most comprehensive set of national accreditation measures for assessing the quality and safety of telemedicine programs and services," said Alexis Gilroy, JD, Partner, Jones Day, Co-Chair, CHQI Telemedicine Standards Committee, and ATA Board Member. "These efforts included a public comment period and beta test cycle."

Last spring, CHQI entered into an agreement with the American Telemedicine Association to develop the next generation of telemedicine accreditation standards. Over the past nine months, a committee of national telemedicine experts updated and expanded ATA's Accreditation Program for Online Patient Consultations, which was established in 2015.

Both CHQI and ATA's boards approved the new TAP Standards and Guide, version 2.0, which replace ATA's accreditation program. 

"While TAP represents the first standards CHQI has introduced to market, three additional accreditation programs ? mental health parity, Cone Beam CT, and health insurance appeals ? are under development," noted Joel V. Brill, MD, FACP, Chief Medical Officer, Predictive Health and CHQI Advisory Board Chair. "CHQI is supporting a value-based, accountable care health system by offering innovative accreditation, compliance monitoring, and outcomes measurement programs."

To obtain more information about CHQI accreditation programs, please contact Rob Mikes, Sales Manager, at (410) 756-1300 or via email at [email protected].

About ClearHealth Quality Institutetm (CHQI)

ClearHealth Quality Institute's (CHQI) mission is to promote quality-based practices for health plans, providers and other stakeholders across the United States and its territories. Our accreditation and certification programs help assess, track and report on trends to enhance key insurance and provider outcomes. CHQI also offers educational programs, publishes issue briefs and underwrites research to raise awareness of patient safety issues and promote best practices. The organization is governed by an independent board and committee system, which is open to a wide range of volunteer members to ensure transparency and accountability. CHQI provides resources to serve patients, providers, payers, government agencies, and other stakeholder groups. To learn more about CHQI, please contact us at (410) 756-1300, [email protected], or visit www.CHQI.com.

SOURCE ClearHealth Quality Institute


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: